Tag: biocon
Browse our exclusive articles!
Biocon gets FDA nod for cancer drugs lenalidomide and dasatinib
Biotechnology firm Biocon Ltd on Tuesday (March 4) said its wholly-owned subsidiary, Biocon Pharma Ltd, has received final approvals from the US Food and...
Biocon launches generic Liraglutide in the UK for diabetes, obesity treatment
Biopharmaceutical firm Biocon Ltd announced the launch of its Glucagon-like Peptide-1 (GLP-1) analog, Liraglutide, in the United Kingdom (U.K.). The drug is used for...
Stocks to Watch on February 25: Biocon, NTPC Green Energy, LIC, Texmaco Rail and more
1 / 8Biocon | Biotechnology firm said its unit Biocon Biologics announced the US market availability of YESINTEK (ustekinumab-kfce), a biosimilar to Stelara (ustekinumab)....
